Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treatment Options and Patient Monitorization-Reference-Cited by-同舟云学术

Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treatment Options and Patient Monitorization

Published:2021-07 Issue: Volume:Volume 15 Page:3221-3230
ISSN:1177-5483
Container-title:Clinical Ophthalmology
language:en
Short-container-title:OPTH

Author:

Figueira João^ORCID,Henriques José,Carneiro Ângela,Marques-Neves Carlos,Flores Rita,Castro-Sousa João Paulo,Meireles Angelina^ORCID,Gomes Nuno,Nascimento João,Amaro Miguel,Silva Rufino^ORCID

Publisher

Informa UK Limited

Subject

Ophthalmology

Reference61 articles.

1. Changes in the diabetic retinopathy epidemiology after 14 years in a population of Type 1 and 2 diabetic patients after the new diabetes mellitus diagnosis criteria and a more strict control of the patients

2. Targeting the Pathophysiology of Diabetic Macular Edema

3. American Diabetes Association. 6. Glycemic targets: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S61–S70. doi:10.2337/dc19-S006

4. Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)

5. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report number 8. Ophthalmol. 1981;88(7):583–600.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain;Ophthalmology and Therapy;2024-05-21

2. Aflibercept Off-Target Effects in Diabetic Macular Edema: An In Silico Modeling Approach;International Journal of Molecular Sciences;2024-03-23

3. Patient-Centered Economic Burden of Diabetic Macular Edema: Retrospective Cohort Study (Preprint);JMIR Public Health and Surveillance;2024-01-25

4. ILUVIEN^® in diabetic macular edema that persists or recurs despite treatment: Results from the Retina.pt^® RIVER audit;European Journal of Ophthalmology;2023-11-28

5. TO MARKET, TO MARKET–2022: MACROMOLECULAR THERAPEUTICS;Medicinal Chemistry Reviews;2023-11-16